Non-syndromic X-linked mental retardation: From a molecular to a clinical point of view

Journal of Cellular Physiology

Volumn 204, Issue 1, 2005, Pages 8-20

  Renieri, A ^a   Pescucci, C ^a   Longo, I ^a   Ariani, F ^a   Mari, F ^a   Meloni, I ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CARRIER PROTEIN; GUANOSINE TRIPHOSPHATASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN ACSL4; PROTEIN AT2; PROTEIN SLC6A8; RAB PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SYNAPSE ASSOCIATED PROTEIN 102; UNCLASSIFIED DRUG;

CHROMATIN ASSEMBLY AND DISASSEMBLY; DENDRITIC CELL; FACE DYSMORPHIA; GENE EXPRESSION REGULATION; HUMAN; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SYNAPSE VESICLE; X LINKED MENTAL RETARDATION;

CHROMOSOMES, HUMAN, X; GENE EXPRESSION REGULATION; HUMANS; MENTAL RETARDATION, X-LINKED; NEURONAL PLASTICITY; SIGNAL TRANSDUCTION;

EID: 20144381139     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20296     Document Type: Review

References (101)

1. Allen KM, Gleeson JG, Bagrodia S, Partington MW, MacMillan JC, Cerione RA, Mulley JC, Walsh CA. 1998. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet 20(1):25-30.
2. Almeida LS, Verhoeven NM, Roos B, Valongo C, Cardoso ML, Vilarinho L, Salomons GS, Jakobs C. 2004. Creatine and guanidinoacetate: Diagnostic markers for inborn errors in creatine biosynthesis and transport. Mol Genet Metab 82(3):214-219.
3. Amir RE, Zoghbi HY. 2000. Rett syndrome: Methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations. Am J Med Genet 97(2):147-152.
4. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23(2):185-188.
5. Bagrodia S, Taylor SJ, Jordon KA, Van Aelst L, Cerione RA. 1998. A novel regulator of p21-activated kinases. J Biol Chem 273(37):23633-23636.
6. Bahi N, Friocourt G, Carrie A, Graham ME, Weiss JL, Chafey P, Fauchereau F, Burgoyne RD, Chelly J. 2003. IL1 receptor accessory protein like, a protein involved in X-linked mental retardation, interacts with Neuronal Calcium Sensor-1 and regulates exocytosis. Hum Mol Genet 12(12):1415-1425.
7. Balmer D, Arredondo J, Samaco RC, LaSalle JM. 2002. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum Genet 110(6):545-552.
8. Battaglia A, Carey JC. 2003. Diagnostic evaluation of developmental delay/mental retardation: An overview. Am J Med Genet 117C(1):3-14.
9. Bergmann C, Zerres K, Senderek J, Rudnik-Schoneborn S, Eggermann T, Hausler M, Mull M, Ramaekers VT. 2003. Oligophrenin 1 (OPHN1) gene mutation causes syndromic X-linked mental retardation with epilepsy, rostral ventricular enlargement and cerebellar hypoplasia. Brain 126(Pt 7):1537-1544.
10. Bienvenu T, Poirier K, Friocourt G, Bahi N, Beaumont D, Fauchereau F, Ben Jeema L, Zemni R, Vinet M, Francis F, Couvert P, Gomot M, Moraine C, van Bokhoven H, Kalscheuer V, Prints S, Gecz J, Ohzaki K, Chaabouni H, Fryns J, Desportes V, Beldjord C, Chelly J. 2002. ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum Mol Genet 11(8):981-991.
11. Billuart P, Bienvenu T, Ronce N, des Portes V, Vinet M, Zemni R, Roest Crollius H, Carrie A, Fauchereau F, Cherry M, Briault S, Hamel B, Fryns J, Beldjord C, Kahn A, Moraine C, Chelly J. 1998. Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 392(6679):923-926.
12. Burgoyne R, Weiss J. 2001. The neuronal calcium sensor family of Ca2+-binding proteins. Biochem J 353:1-12.
13. Cao Y, Traer E, Zimmerman GA, McIntyre TM, Prescott SM. 1998. Cloning, expression, and chromosomal localization of human long-chain fatty acid-CoA ligase 4 (FACL4). Genomics 49:327-330.
14. Carrie A, Jun L, Bienvenu T, Vinet MC, McDonell N, Couvert P, Zemni R, Cardona A, Van Buggenhout G, Frints S, Hamel B, Moraine C, Ropers HH, Strom T, Howell GR, Whittaker A, Ross MT, Kahn A, Fryns JP, Beldjord C, Marynen P, Chelly J. 1999. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet 23(1):25-31.
15. Chechlacz M, Gleeson JG. 2003. Is mental retardation a defect of synapse structure and function? Pediatr Neurol 29(1):11-17.
16. Chelly J, Mandel J. 2001. Monogenic causes of X-linked mental retardation. Nat Rev Genet 2(9):669-680.
17. Colantuoni C, Jeon OH, Hyder K, Chenchik A, Khimani AH, Narayanan V, Hoffman EP, Kaufmann WE, Naidu S, Pevsner J. 2001. Gene expression profiling in postmortem Rett Syndrome brain: Differential gene expression and patient classification. Neurobiol Dis 8(5):847-865.
18. Couvert P, Bienvenu T, Aquaviva C, Poirier K, Moraine C, Gendrot C, Verloes A, Andres C, Le Fevre AC, Souville I, Steffann J, des Portes V, Ropers HH, Yntema HG, Fryns JP, Briault S, Chelly J, Cherif B. 2001. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet 10:941-946.
19. D'Adamo P, Menegon A, Lo Nigro C, Grasso M, Gulisano M, Tamanini F, Bienvenu T, Gedeon A, Oostra B, Wu S, Tandon A, Valtorta F, Balch W, Chelly J, Toniolo D. 1998. Mutations in GDI1 are responsible for X-linked non-specific mental retardation. Nat Genet 19(2):134-139.
20. D'Adamo P, Welzl H, Papadimitriou S, Raffaele di Barletta M, Tiveron C, Tatangelo L, Pozzi L, Chapman PF, Knevett SG, Ramsay MF, Valtorta F, Leoni C, Menegon A, Wolfer DP, Lipp HP, Toniolo D. 2002. Deletion of the mental retardation gene Gdil impairs associative memory and alters social behavior in mice. Hum Mol Genet 11(21):2567-2580.
21. da Silva JS, Dotti CG. 2002. Breaking the neuronal sphere: Regulation of the actin cytoskeleton in neuritogenesis. Nat Rev Neurosci 3(9):694-704.
22. Daniels RH, Bokoch GM. 1999. p21-activated protein kinase: A crucial component of morphological signaling? Trends Biochem Sci 24(9):350-355.
23. de Hoop MJ, Huber LA, Stenmark H, Williamson E, Zerial M, Parton RG, Dotti CG. 1994. The involvement of the small GTP-binding protein Rab5a in neuronal endocytosis. Neuron 13(1):11-22.
24. de Wit H, Lichtenstein Y, Kelly RB, Geuze HJ, Klumperman J, van der Sluijs P. 2001. Rab4 regulates formation of synaptic-like microvesicles from early endosomes in PC12 cells. Mol Biol Cell 12(11):3703-3715.
25. Dickson BJ. 2001. Rho GTPases in growth cone guidance. Curr Opin Neurobiol 11(1):103-110.
26. Feder M, Pas J, Wyrwicz LS, Bujnicki JM. 2003. Molecular phylogenetics of the RrmJ/fibrillarin superfamily of ribose 2′-O-methyltransferases. Gene 302(1-2):129-138.
27. Freude K, Hoffmann K, Jensen LR, Delatycki MB, des Portes V, Moser B, Hamel B, van Bokhoven H, Moraine C, Fryns JP, Chelly J, Gecz J, Lenzner S, Kaischeuer VM, Ropers HH. 2004. Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation. Am J Hum Genet 75(2):305-309.
28. Frints SG, Froyen G, Marynen P, Fryns JP. 2002. X-linked mental retardation: Vanishing boundaries between non-specific (MRX) and syndromic (MRXS) forms. Clin Genet 62(6):423-432.
29. Gallinat S, Busche S, Raizada MK, Sumners C. 2000. The angiotensin II type 2 receptor: An enigma with multiple variations. Am J Physiol Endocrinol Metab 278(3):E357-374.
30. Gecz J, Gedeon A, Sutherland G, Mulley J. 1996. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet 13(1):105-108.
31. Gendron L, Laflamme L, Rivard N, Asselin C, Payet M, Gallo-Payet N. 1999. Signals from the AT2 (angiotensin type 2) receptor of angiotensin II inhibit p21 ras and activate MAPK (mitogen activated protein kinase) to induce morphological neuronal differentiation in NG108-15 cells. Mol Endocrinol 13:1615-1626.
32. Gu Y, Shen Y, Gibbs R, Nelson D. 1996. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat Genet 13(1):109-113.
33. Hall A. 1998. Rho GTPases and the actin cytoskeleton. Science 279(5350):509-514.
34. Hillman MA, Gecz J. 2001. Fragile XE-associated familial mental retardation protein 2 (FMR2) acts as a potent transcription activator. J Hum Genet 46(5): 251-259.
35. Ishizaki H, Miyoshi J, Kamiya H, Togawa A, Tanaka M, Sasaki T, Endo K, Mizoguchi A, Ozawa S, Takai Y. 2000. Role of rab GDP dissociation inhibitor alpha in regulating plasticity of hippocampal neurotransmission. Proc Natl Acad Sci USA 97(21):11587-11592.
36. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19(2):187-191.
37. Kadonaga JT. 1998. Eukaryotic transcription: An interlaced network of transcription factors and chromatin-modifying machines. Cell 92(3):307-313.
38. Kalscheuer VM, Freude K, Musante L, Jensen LE, Yntema HG, Gecz J, Sefiani A, Hoffmann K, Moser B, Haas S, Gurok U, Haesler S, Aranda B, Nshedjan A, Tzschach A, Hartmann N, Roloff TC, Shoichet S, Hagens O, Tao J, Van Bokhoven H, Turner G, Chelly J, Moraine C, Fryns JP, Nuber U, Hoeltzenbein M, Scharff C, Scherthan H, Lenzner S, Hamel BC, Schweiger S, Ropers HH. 2003. Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation. Nat Genet 35(4):313-315.
39. Kato M, Das S, Petras K, Kitamura K, Morohashi K, Abuelo DN, Barr M, Bonneau D, Brady AF, Carpenter NJ, Cipero KL, Frisone F, Fukuda T, Guerrini R, Iida E, Itoh M, Lewanda AF, Nanba Y, Oka A, Proud VK, Saugier-Veber P, Schelley SL, Selicorni A, Shaner R, Silengo M, Stewart F, Sugiyama N, Toyama J, Toutain A, Vargas AL, Yanazawa M, Zackai EH, Dobyns WB. 2004. Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation. Hum Mutat 23(2):147-159.
40. Katz LC, Shatz CJ. 1996. Synaptic activity and the construction of cortical circuits. Science 274(5290):1133-1138.
41. Kerr B, Turner G, Mulley J, Gedeon A, Partington M. 1991. Non-specific X linked mental retardation. J Med Genet 28(6):378-382.
42. Kobayashi K, Kuroda S, Fukata M, Nakamura T, Nagase T, Nomura N, Matsuura Y, Yoshida-Kubomura N, Iwamatsu A, Kaibuchi K. 1998. p140Sra-1 (specifically Rac1-associated protein) is a novel specific target for Rac1 small GTPase. J Biol Chem 273(1):291-295.
43. Kutsche K, Yntema H, Brandt A, Jantke I, Nothwang HG, Orth U, Boavida MG, David D, Chelly J, Fryns JP, Moraine C, Ropers HH, Hamel BC, van Bokhoven H, Gal A. 2000. Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nat Genet 26(2):247-250.
44. Lenski C, Abidi F, Meindl A, Gibson A, Platzer M, Frank Kooy R, Lubs HA, Stevenson RE, Ramser J, Schwartz CE. 2004. Novel truncating mutations in the polyglutamine tract binding protein 1 gene (PQBP1) cause Renpenning syndrome and X-linked mental retardation in another family with microcephaly. Am J Hum Genet 74(4):777-780.
45. Longo I, Frints SG, Fryns JP, Meloni I, Pescucci C, Ariani F, Borghgraef M, Raynaud M, Marynen P, Schwartz C, Renieri A, Froyen G. 2003. A third MRX family (MRX68) is the result of mutation in the long chain fatty acid-CoA ligase 4 (FACL4) gene: Proposal of a rapid enzymatic assay for screening mentally retarded patients. J Med Genet 40(1):11-17.
46. Lucius R, Gallinat S, Rosenstiel P, Herdegen T, Sievers J, Unger T. 1998. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med 188(4):661-670.
47. Luo L. 2000. Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 1(3): 173-180.
48. Manser E, Loo T, KOoh C, Zhao Z, Chen X, Tan L, Tan I, Leung T, Lim L. 1998. PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. MoI Cell Biol 1:183-192.
49. Mashek DG, Bornfeldt KE, Coleman RA, Berger J, Bernlohr DA, Black P, DiRusso CC, Farber SA, Guo W, Hashimoto N, Khodiyar V, Kuypers FA, Maltais LJ, Nebert DW, Renieri A, Schaffer JE, Stahl A, Watkins PA, Vasiliou V, Yamamoto TT. 2004. Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J Lipid Res 45(10):1958-1961.
50. Matus A. 2000. Actin-based plasticity in dendritic spines. Science 290(5492):754-758.
51. McDowell TL, Gibbons RJ, Sutherland H, O'Rourke DM, Bickmore WA, Pombo A, Turley H, Gatter K, Picketts DJ, Buckle VJ, Chapman L, Rhodes D, Higgs DR. 1999. Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. Proc Natl Acad Sci USA 96(24):13983-13988.
52. Meloni I, Muscettola M, Raynaud M, Longo I, Bruttini M, Moizard M, Gomot M, Chelly J, das Portes V, Fryns J, Ropers H, Magi B, Bellan C, Volpi N, Yntema H, Lewis S, Schaffer J, Renieri A. 2002. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat Genet 30:436-440.
53. Merienne K, Jacquot S, Trivier E, Pannetier S, Rossi A, Scott C, Schinzel A, Castellan C, Kress W, Hanauer A. 1998. Rapid immunoblot and kinase assay tests for a syndromal form of X linked mental retardation: Coffin-Lowry syndrome. J Med Genet 35(11):890-894.
54. Merienne K, Jacquot S, Pannetier S, Zeniou M, Bankier A, Gecz J, Mandel JL, Mulley J, Sassone-Corsi P, Hanauer A. 1999. A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation. Nature Genet 22:13-14.
55. Merienne K, Pannetier S, Harel-Bellan A, Sassone-Corsi P. 2001. Mitogen-regulated RSK2-CBP interaction controls their kinase and acetylase activities. Mol Cell Biol 21(20):7089-7096.
56. Muller BM, Kistner U, Kindler S, Chung WJ, Kuhlendahl S, Fenster SD, Lau LF, Veh RW, Huganir RL, Gundelfinger ED, Garner CC. 1996. SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo. Neuron 17(2):255-265.
57. Mulley JC, Kerr B, Stevenson R, Lubs H. 1992. Nomenclature guidelines for X-linked mental retardation. Am J Med Genet 43(1-2):383-391.
58. Neri G, Chiurazzi P. 1999. X-linked mental retardation. Adv Genet 41:55-94.
59. Novick P, Zerial M. 1997. The diversity of Rab proteins in vesicle transport. Curr Opin Cell Biol 9(4):496-504.
60. Oberlè I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Berrtheas M, Mandel JL. 1991. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-1102.
61. Okazawa H, Sudol M, Rich T. 2001. PQBP-1 (Np/PQ): A polyglutamine tract-binding and nuclear inclusion-forming protein. Brain Res Bull 56(3-4):273-280.
62. Orrico A, Lam C, Galli L, Dotti MT, Hayek G, Tong SF, Poon PM, Zappella M, Federico A, Sorrentino V. 2000. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett 481(3):285-288.
63. Philip N, Chabrol B, Lossi AM, Cardoso C, Guerrini R, Dobyns WB, Raybaud C, Villard L. 2003. Mutations in the oligophrenin-1 gene (OPHNl) cause X linked congenital cerebellar hypoplasia. J Med Genet 40(6):441-446.
64. Piccini M, Vitelli F, Bruttini M, Pober B, Jonsson JJ, Villanova M, Zollo M, Borsani G, Ballabio A, Renieri A. 1998. FACL4, a new gene encoding Long Chain Acyl-CoA Synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis and mental retardation. Genomics 47:350-358.
65. Purpura DP. 1974. Dendritic spine "dysgenesis" and mental retardation. Science 186(4169):1126-1128.
66. Ramakers GJ. 2002. Rho proteins, mental retardation and the cellular basis of cognition. Trends Neurosci 25(4):191-199.
67. Ramser J, Winnepenninckx B, Lenski C, Errijgers V, Platzer M, Schwartz CE, Meindl A, Kooy RF. 2004. A splice site mutation in the methyltransferase gene FTSJ1 in Xp11.23 is associated with non-syndromic mental retardation in a large Belgian family (MRX9). J Med Genet 41(9):679-683.
68. Ropers HH, Hamel B. 2004. X-linked mental retardation. Nat Rev Genet (in press).
69. Rosati M, Franze A, Matarazzo MR, Grimaldi G. 1999. Coding region intron/exon organization, alternative splicing, and X-chromosome inactivation of the KRAB/FPB-domain-containing human zinc finger gene ZNF41. Cytogenet Cell Genet 85(3-4):291-296.
70. Rosenberg EH, Almeida LS, Kleefstra T, deGrauw RS, Yntema HG, Bahi N, Moraine C, Ropers HH, Fryns JP, deGrauw TJ, Jakobs C, Salomons GS. 2004. High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am J Hum Genet 75(1):97-105.
71. Rosenstiel P, Gallinat S, Arlt A, Unger T, Sievers J, Lucius R. 2002. Angiotensin AT2 receptor ligands: Do they have potential as future treatments for neurological disease? CNS Drugs 16:145-153.
72. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malmgren H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I, Maddalena A, Spiegel R, Schinzel A, Marcos G, Schorderet D, Schaap T, Maccioni L, Russo S, Jacobs A, Schwartz C, Mandel JL. 1994. A multicenter study on genotype-phenotype correlation in the fragile X syndrome, using direct diagnosis with probe StB12.3: The first 2253 cases. Am J Hum Genet 55:225-237.
73. Salomons GS, van Dooren SJ, Verhoeven NM, Marsden D, Schwartz C, Cecil KM, DeGrauw TJ, Jakobs C. 2003. X-linked creatine transporter defect: An overview. J Inherit Metab Dis 26(2-3):309-318.
74. Schenck A, Bardoni B, Langmann C, Harden N, Mandel JL, Giangrande A. 2003. CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein. Neuron 38(6):887-898.
75. Schultz DC, Friedman JR, Rauscher FJ IIIrd. 2001. Targeting histone deacetylase complexes via KRAB-zinc finger proteins: The PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD. Genes Dev 15(4):428-443.
76. Shilatifard A. 1998. Factors regulating the transcriptional elongation activity of RNA polymerase II. Faseb J 12(14):1437-1446.
77. Shoichet SA, Hoffmann K, Menzel C, Trautmann U, Moser B, Hoeltzenbein M, Echenne B, Partington M, Van Bokhoven H, Moraine C, Fryns JP, Chelly J, Rott HD, Ropers HH, Kaischeuer VM. 2003. Mutations in the ZNF41 gene are associated with cognitive deficits: Identification of a new candidate for X-linked mental retardation. Am J Hum Genet 73(6):1341-1354.
78. Sparrow S, Balla D, Cicchetti D. 1984. Vineland adaptive behavior scales. Service AG, editor. MN: Circle Pines.
79. Stromme P, Mangelsdorf M, Shaw M, Lower K, Lewis S, Bruyere H, Lutcherath V, Gedeon A, Wallace R, Scheffer I, Turner G, Partington M, Frints S, Fryns J, Sutherland G, Mulley J, Gecz J. 2002. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet 30(4): 441-445.
80. Tarpey P, Parnau J, Blow M, Woffendin H, Bignell G, Cox C, Cox J, Davies H, Edkins S, Holden S, Korny A, Mallya U, Moon J, O'Meara S, Parker A, Stephens P, Stevens C, Teague J, Donnelly A, Mangelsdorf M, Mulley J, Partington M, Turner G, Stevenson R, Schwartz C, Young I, Easton D, Bobrow M, Futreal PA, Stratton MR, Gecz J, Wooster R, Raymond FL. 2004. Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardation. Am J Hum Genet 75(2):318-324.
81. Traynor J, Agarwal P, Lazzeroni L, Francke U. 2002. Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med Genet 3(1):12.
82. Trivier E, De Cesare D, Jacquot S, Pannetier S, Zackai E, Young I, Mandel JL, Sassone-Corsi P, Hanauer A. 1996. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 384:567-570.
83. Tudor M, Akbarian S, Chen RZ, Jaenisch R. 2002. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci USA 99(24):15536-15541.
84. Turner G, Turner B. 1974. X-linked mental retardation. J Med Genet 11(2):109-113.
85. Van Bohlen O, Walther T, Bader M, Albrecht D. 2001. Genetic deletion of angiotensin AT2 receptor leads to increased cell numbers in different brain structures. Regul Pept 99:209-216.
86. Verkerk A, Piretti M, Sutcliffe J, Fu Y, Kuhl D, Pizzuti A, Reiner O. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
87. Vervoort VS, Beachem MA, Edwards PS, Ladd S, Miller KE, de Mollerat X, Clarkson K, DuPont B, Schwartz CE, Stevenson RE, Boyd E, Srivastava AK. 2002. AGTR2 mutations in X-linked mental retardation. Science 296(5577): 2401-2403.
88. Villard L, Fontes M. 2002. Alpha-thalassemia/mental retardation syndrome, X-linked (ATR-X, MIM#301040, ATR-X/XNP/XH2 gene MIM#300032). Eur J Hum Genet 10:223-225.
89. Wallimann T, Hemmer W. 1994. Creatine kinase in non-muscle tissues and cells. Mol Cell Biochem 133(134):193-220.
90. Walton M, Dragunow M. 2000. Is CREB a key to neuronal survival? Trends Neurosci 23:48-53.
91. Wang YE, Esbensen P, Bentley D. 1998. Arginine kinase expression and localization in growth cone migration. J Neurosci 18(3):987-998.
92. Waragai M, Lammers CH, Takeuchi S, Imafuku I, Udagawa Y, Kanazawa I, Kawabata M, Mouradian MM, Okazawa H. 1999. PQBP-1, a novel poly-glutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum Mol Genet 8(6):977-987.
93. Wittwer F, van der Straten A, Keleman K, Dickson BJ, Hafen E. 2001. Lilliputian: An AF4/FMR2-related protein that controls cell identity and cell growth. Development 128(5):791-800.
94. Wu SK, Zeng K, Wilson IA, Balch WE. 1996. Structural insights into the function of the Rab GDI superfamily. Trends Biochem Sci 21(12):472-476.
95. Xue Y, Gibbons R, Yan Z, Yang D, McDowell TL, Sechi S, Qin J, Zhou S, Higgs D, Wang W. 2003. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc Natl Acad Sci USA 100(19): 10635-10640.
96. Yeh SH, Lin CH, Gean PW. 2004. Acetylation of nuclear factor-kappaB in rat amygdala improves long-term but not short-term retention of fear memory. Mol Pharmacol 65(5):1286-1292.
97. Yntema H, Poppelaars F, Derksen E, Oudakker A, Van Roosmalen T, Jacobs A, Obbema H, Brunner H, Hamel B, Van Bokhoven H. 2002a. Expanding phenotype of XNP mutations: Mild to moderate mental retardation. Am J Med Genet 110(3):243-247.
98. Yntema HG, Kleefstra T, Oudakker AR, Romein T, de Vries BB, Nillesen W, Sistermans EA, Brunner HG, Hamel BC, van Bokhoven H. 2002b. Low frequency of MECP2 mutations in mentally retarded males. Eur J Hum Genet 10(8):487-490.
99. Yntema HG, Oudakker AR, Kleefstra T, Hamel BC, van Bokhoven H, Chelly J, Kalscheuer VM, Fryns JP, Raynaud M, Moizard MP, Moraine C. 2002c. In-frame deletion in MECP2 causes mild nonspecific mental retardation. Am J Med Genet 107(1):81-83.
100. Zechner U, Wilda M, Kehre-Sawatzki H, Vogel W, Fundele R, Hameister H. 2001. A high density of X-linked genes for general cognitive ability: A run-away process shaping human evolution? TRENDS in Genetics 17(12):697-701.
101. Zemni R, Bienvenu T, Vinet MC, Sefiani A, Carrie A, Billuart P, McDonell N, Couvert P, Francis F, Chafey P, Fauchereau F, Friocourt G, des Portes V, Cardona A, Frints S, Meindl A, Brandau O, Ronce N, Moraine C, van Bokhoven H, Ropers HH, Sudbrak R, Kahn A, Fryns JP, Beldjord C, Chelly J. 2000. A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat Genet 24(2):167-170.